Skip to main navigation Skip to search Skip to main content

Monomeric C-reactive protein binds and neutralizes receptor activator of NF-κB ligand-induced osteoclast differentiation

  • Zhe Kun Jia
  • , Hai Yun Li
  • , Yu Lin Liang
  • , Lawrence Albert Potempa
  • , Shang Rong Ji
  • , Yi Wu
  • Lanzhou University
  • Xi'an Jiaotong University
  • Roosevelt University Chicago

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

C-reactive protein (CRP) is an established marker of rheumatoid arthritis (RA) but with ill-defined actions in the pathogenesis. Here, we show that CRP regulates the differentiation of osteoclasts, a central mediator of joint inflammation and bone erosion in RA, in a conformation- and receptor activator of NF-κB ligand (RANKL)-dependent manner. CRP in the native conformation is ineffective, whereas the monomeric conformation (mCRP) actively modulates osteoclast differentiation through NF-κB and phospholipase C signaling. Moreover, mCRP can bind RANKL, the major driver of osteoclast differentiation, and abrogate its activities. The binding and inhibition of RANKL are mediated by the cholesterol binding sequence (CBS) of mCRP. Corroborating the in vitro results, CRP knockout exacerbates LPS-induced bone resorption in mice. These results suggest that mCRP may be protective in joint inflammation by inhibiting pathological osteoclast differentiation and that the CBS peptide could be exploited as a potential RANKL inhibitor.

Original languageEnglish
Article number234
JournalFrontiers in Immunology
Volume9
Issue numberFEB
DOIs
StatePublished - 19 Feb 2018

Keywords

  • C-reactive protein
  • Inflammation
  • Osteoclast
  • Receptor activator of NF-κB ligand
  • Rheumatoid arthritis

Fingerprint

Dive into the research topics of 'Monomeric C-reactive protein binds and neutralizes receptor activator of NF-κB ligand-induced osteoclast differentiation'. Together they form a unique fingerprint.

Cite this